Quintiles Transnational Corporation provides clinical, commercial, consulting, and capital solutions to biopharmaceutical industry. The company's clinical development services cover trial types, such as phase I/IIa, phase II/III, late phase, medical devices, and emerging biopharmaceutical; trial services, including bioanalytical and ADME laboratory, biostatistics, biosimilars, central laboratory, clinical monitoring, data management, ECG, functional, lifecycle safety, patient and investigator recruitment, medical writing, model-based drug development, regulatory, and site ID and start up; data intelligence services comprising reporting and analytics, data-driven processes, data archival and warehousing, and systems as a service; and Quintiles Infosario, a data-driven service. The company's commercial services comprise areas, such as sales solutions, clinical education and nurse advisory, medical science liaisons, market access implementation, medical communications, late phase, brand and patient-centric solutions, and product solutions; and consulting services cover practice areas, such as product development and commercialization, market access, regulatory and quality, and market intelligence with late phase, and IT strategy and implementation solutions. Quintiles Transnational Corp. capital solutions comprise areas, such as partnership structures, late phase, alliance management, and partnership case studies. Quintiles Transnational Corp. has strategic partnerships with dabl Limited and Allscripts Healthcare Solutions, Inc. The company was founded in 1990 and is based in Durham, North Carolina. The company has locations in Africa, Asia, Australia, New Zealand, Europe, North and Central America, and South America. Quintiles Transnational Corp. operates as a subsidiary of Quintiles Transnational Holdings Inc.
